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 INTRODUCTION
In mammalian cells dense core lysosomes (DCL) are of
fundamental importance to the maintenance of cellular
homeostasis. They are required not only for the processing of
endocytosed nutrients such as lipoprotein particles, but also for
cellular responses to external stimuli including the down-
regulation of ligand activated growth-factor receptors, and
autophagy (reviewed by Kornfeld and Mellman, 1989). Loss
of lysosomal function can have severe consequences, and there
are over 30 distinct diseases directly attributable to lysosomal
dysfunction (Gieselmann, 1995). Although lysosomal storage
diseases (LSD) generally arise from defects in a single
acid hydrolase, they are often characterised by complex
pathologies, which in many cases remain poorly understood. 
In order to understand the intracellular consequences of LSD
a knowledge of DCL biogenesis is essential. Ultrastructural
analysis of fibroblasts has identified lysosomes as spherical
electron-dense organelles approximately 300-500 nM in
diameter in which endocytosed tracers accumulate. Thus
traditional models of the endocytic pathway have regarded
DCLs as the terminal destination, and primary site of
degradation, for endocytosed macromolecules (Kornfeld and
Mellman, 1989). However, a number of recent studies have
suggested that the situation may be more complex, and that the
late endocytic pathway is much more dynamic than the
traditional model suggests (reviewed by Luzio et al., 2000). In
particular one revised model suggests that late endosomes and
DCLs undergo multiple cycles of fusion and condensation, and
highlights the importance of the late endosome-lysosome
hybrid organelle (ELH) in this process (Bright et al., 1997;
Futter et al., 1996; Mullock et al., 1998). 
4099Journal of Cell Science 113, 4099-4108 (2000)
Printed in Great Britain © The Company of Biologists Limited 2000
JCS1776
A number of recent studies have highlighted the
importance of lipid domains within endocytic organelles
in the sorting and movement of integral membrane
proteins. In particular, considerable attention has become
focussed upon the role of the unusual phospholipid
lysobisphosphatidic acid (LBPA). This lipid appears to
be directly involved in the trafficking of cholesterol
and glycosphingolipids, and accumulates in a number
of lysosomal storage disorders. Antibody-mediated
disruption of LBPA function also leads to mis-sorting of
cation-independent mannose 6-phosphate receptors. We
now report that the converse is also true, and that
spontaneous loss of cation-independent mannose 6-
phosphate receptors from a rat fibroblast cell line led to the
formation of aberrant late endocytic structures enriched in
LBPA. Accumulation of LBPA was directly dependent
upon the loss of the receptors, and could be reversed by
expression of bovine cation-independent mannose 6-
phosphate receptors in the mutant cell line.
Ultrastructural analysis indicated that the abnormal
organelles were electron-dense, had a multi-lamellar
structure, accumulated endocytosed probes, and were
distinct from dense-core lysosomes present within the same
cells. The late endocytic structures present at steady state
within any particular cell likely reflect the balance of
membrane traffic through the endocytic pathway of that
cell, and the rate of maturation of individual endocytic
organelles. Moreover, there is considerable evidence which
suggests that cargo receptors also play a direct mechanistic
role in membrane trafficking events. Therefore, loss of such
a protein may disturb the overall equilibrium of the
pathway, and hence cause the accumulation of aberrant
organelles. We propose that this mechanism underlies the
phenotype of the mutant cell line, and that the formation
of inclusion bodies in many lysosomal storage diseases is
also due to an imbalance in membrane trafficking within
the endocytic pathway.
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The majority of lysosomal hydrolases are delivered to the
endocytic pathway via a mannose 6-phosphate (M6P)
recognition signal (Dahms et al., 1989). This signal is created
through the sequential actions of two enzymes, UDP-GlcNAc:
lysosomal enzyme GlcNAc-phosphotransferase, and GlcNAc-
1-phosphodiester α-N-acetylglucosaminidase during passage
of the newly synthesized hydrolase to and through the
Golgi (Baranski et al., 1991; Kornfeld and Mellman, 1989).
Subsequently the mannose 6-phosphorylated proteins bind to
specific receptors (M6PRs) in the trans Golgi network (TGN)
and are thus transported to the endocytic pathway. Following
delivery, the acidic endosomal milieu causes dissociation of
hydrolase and receptor, with the latter recycling to the TGN to
mediate further rounds of transport (Dahms et al., 1989).
Failure to form the M6P signal due to defective
phosphotransferase activity is the underlying defect in the
LCDs mucolipidosis types II and III (Lang et al., 1985), and a
similar phenotype to mucolipidosis type II (I-cell disease) is
obtained in mice lacking M6PRs (Dittmer et al., 1998).
Trafficking of the cation-independent M6PR (ciM6PR)
within the endocytic pathway can be perturbed by antibodies
against lysobisphosphatidic acid (LBPA; Kobayashi et al.,
1999). This lipid is mainly restricted to internal membranes
within late endocytic organelles, and has an unusual
stereoconfiguration which renders it resistant to most
phospholipases, and particularly prone to forming non-bilayer
structures (Kobayashi et al., 1998a). LBPA-rich membranes are
likely to be involved in membrane protein sorting from late
endosomes, as evidenced by the perturbation of CD63
trafficking in cells treated with drugs that disrupt the function
of this lipid (Kobayashi et al., 2000). They also appear to be
the primary sites of glycosphingolipid breakdown (Schuette et
al., 1999), and play a major role in cholesterol metabolism
(Kobayashi et al., 1999). 
In the present study we show that the spontaneous loss of
ciM6PR from a transfected rat fibroblast line resulted in the
accumulation of abnormal late endocytic structures enriched in
cholesterol and LBPA. This effect could be reversed by
expression of the bovine receptor. Quantitative electron
microscopic analysis of the mutant cell line revealed an
abnormal accumulation of multi-lamellar bodies (MLB) and
concomitant decrease in multi-vesicular late endosomes and
DCLs. These results suggest a central role of lipid trafficking
and/or metabolism in controlling the biogenesis of lysosomes.
We propose that a common defect of membrane trafficking
through the late endocytic pathway may underlie the
pathologies of many LSDs.
MATERIALS AND METHODS
Cell lines
Fischer Rat Embryonic Fibroblasts (Rat1; Topp, 1981) were
maintained in RPMI 1640 medium supplemented with 10% foetal calf
serum, 1% non-essential amino acids, 10 mM Na pyruvate, 2 mM
glutamine, 50 i.u./ml penicillin, and 50 µg/ml streptomycin, in a
humidified 95% air/5% CO2 atmosphere at 37°C. Cells were
transfected by electroporation with vectors conferring resistance to
hygromycin, and clonal cell lines derived essentially as described
previously (Reaves and Banting, 1994). Clones were maintained in
medium supplemented with 200 µg/ml hygromycin (Roche, Lewes,
UK). For the recovery experiments shown in Fig. 8, clone 2 cells were
transfected with pSREP93-ciM6PR using Fugene 6 (Roche)
according to the manufacturer’s instructions. After 24 hours the media
was changed and fresh media containing 5 µg/ml puromycin added.
Cells were processed for immunofluorescence microscopy after a
further 10 days in culture in the continued presence of puromycin.
Antibodies and cDNA
Cathepsin D was isolated from rat liver by pepstatin A affinity
chromatography as described by Stewart and co-workers (Stewart et
al., 1994). Polyclonal antisera were raised against the purified protein
in New Zealand White rabbits by established techniques (Harlow and
Lane, 1988). Polyclonal antisera towards rat ciM6PR (Reaves et al.,
1996) and TGN38 (Luzio et al., 1990), and monoclonal GM-10 (anti-
rat lgp120; Reaves et al., 1996) have been described elsewhere. Rabbit
anti-(γ-adaptin; Seaman et al., 1996) was a gift from Dr M. Robinson
(University of Cambridge), rabbit anti-EEA1 from Dr M. Clague
(University of Liverpool), and mouse monoclonal 6C4 against LBPA
(Kobayashi et al., 1998b) from Dr T. Kobayashi (Saitama, Japan).
FITC-labelled goat anti-(mouse IgG), Texas Red-labelled donkey
anti-(rabbit IgG) and peroxidase-labelled donkey anti-(rabbit IgG)
were all obtained from Amersham (Little Chalfont, UK). Goat anti-
mouse IgG conjugated to 10 nm colloidal gold was purchased from
Sigma (Poole, UK).
The cloning and mutagenesis of cDNA encoding rat Vps34p will
be described elsewhere (P. E. Row et al., unpublished). Wild-type and
mutant constructs were sub-cloned into the mammalian expression
vector ΔpMEP4 (Girotti and Banting, 1996). Bovine ciM6PR cDNA
(Lobel et al., 1989) was kindly provided by Dr S. Kornfeld (St Louis,
USA). The entire coding sequence was sub-cloned into pSREP93, a
derivative of pMEP4 (Invitrogen, Groningen, Holland) in which the
metallothionein promotor was replaced with the SRα promotor
(Takebe et al., 1988), and the hph gene replaced by the pac gene
conferring resistance to puromycin (de la Luna and Ortin, 1992). 
Biosynthetic radiolabelling
Rat1 cell lines (>80% confluent) growing on 60 mm tissue culture
dishes were washed twice with PBS, then incubated in methionine and
cysteine free DMEM (Sigma) containing 2.2 g/l Na bicarbonate, 5%
v/v dialysed new-born calf serum, and inhibitors if required for 1 hour
at 37°C in a gassed incubator. After washing twice with PBS, 1.2 ml
of methionine and cysteine free medium containing 100 µCi Trans35S-
Label (ICN Biomedicals Ltd, Thame, UK) was added, and the cells
incubated at 37°C for 30 minutes. They were then transferred to ice,
washed three times with ice-cold PBS/5 mg/ml BSA and lysed as
described previously (Davidson, 1995). Labelled ciM6PR was
immunoprecipitated, and analysed by SDS-PAGE and
phosphorimaging. 
Starvation induced autophagy
Starvation-induced autophagy was assayed by a modification of the
method of Petiot and colleagues (Petiot et al., 2000). Rat1 cell lines
(>80% confluent) growing on 60 mm tissue culture dishes were
washed twice with PBS, then incubated in methionine free α-MEM
(Sigma) containing 2.2 g/l Na bicarbonate and 5% v/v dialysed new-
born calf serum for 2 hours at 37°C in a gassed incubator. After
washing twice with PBS, 1.5 ml of methionine free medium
containing 50 µCi Trans35S-Label (ICN Biomedicals Ltd, Thame,
UK) and 10% v/v dialyzed serum was added and the cells incubated
for a further 16 hours. The labelled cells were then washed with PBS
and autophagy induced by incubation at 37°C in 2 ml Hanks’ balanced
salt solution (Sigma) containing 0.1 mM methionine, 0.1% BSA and
inhibitors as required. After 1 hour the medium was replaced and the
incubation continued for a further 4 hours. The final chase medium
was retained and the cells recovered from the dishes by scraping into
PBS. All fractions were treated with ice-cold TCA (10% w/v final
concentration) and separated into soluble and precipitated material by
centrifugation. The various fractions were then analysed by liquid
B. J. Reaves and others
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scintillation counting. Results are expressed as the sum of the TCA
soluble material in the cells and final medium as a percentage of the
total recovered radioactivity.
Microscopy
Indirect immunofluorescence microscopy was performed as described
previously (Reaves et al., 1996) using Rat1 cell lines grown on glass
coverslips. Prior to staining of unesterified cholesterol using filipin
(Sigma), cells were incubated in the presence or absence of 3 µg/ml
U18666A (Affiniti research products, Exeter, UK) for 6 hours at 37°C.
They were then fixed with 2% paraformaldehyde in PBS for 20
minutes at room temperature, washed 3 times in PBS and
permeabilized and blocked with 0.05 mg/ml filipin in 0.2% BSA/PBS
for 20 minutes. All subsequent incubations, including antibody
solutions, contained filipin and 0.2% BSA in PBS. 
Prior to preparation for electron microscopic analysis BSA-5 nm
gold was internalised for 4 hours followed by a 20 hour chase as
described previously (Bright et al., 1997). Quantitation of the number,
size and LBPA labelling density of BSA-gold positive late endocytic
structures was performed as in our previous studies (Bright et al.,
1997; Mullock et al., 1998). Late endosomes were defined as
structures containing the BSA-gold which were electron-lucent, and
MLBs as labelled structures which had an electron-dense luminal
content and multilamellar intraluminal membranes. DCL were defined
as previously (Bright et al., 1997). To generate the data shown in Fig.
6C-E derived from samples embedded in epoxy resin, 34 cell profiles
containing a total of 69 BSA-gold loaded organelles, and 70 cell
profiles containing a total of 81 BSA-gold loaded organelles, were
scored from clones 1 and 2, respectively. To generate the data shown
in Fig. 7C derived from ultra-thin frozen sections labelled with anti-
LBPA, 96 cell profiles containing a total of 191 BSA-gold loaded
organelles, and 90 cell profiles containing a total of 107 BSA-gold
loaded organelles, were scored from clones 1 and 2, respectively. The
distribution of gold, and the size of gold-labelled organelles was not
affected by the sample preparation method.
RESULTS
Clone 2 cells do not express ciM6PR 
Previously, we demonstrated a role for phosphatidylinositol 3-
kinase activity in trafficking within the endocytic pathway
(Reaves et al., 1996). During studies designed to extend this
work we isolated a hygromycin resistant cell line (clone 2)
deficient in ciM6PR. Western blotting of clone 2 cells showed
that in contrast to the parental cell line, or clones 1, 3 or 4, it
did not express any detectable ciM6PR staining at steady state
(Fig. 1). The result shown utilised an antibody directed towards
the cytoplasmic tail of the receptor, but an identical pattern was
observed when a luminal epitope was used (data not shown).
All lines expressed equivalent amounts of the control protein
γ-adaptin (Fig. 1). A number of mouse cell lines which
apparently lack ciM6PR have been identified. For example
P388D1 cells do not synthesize any gene product, whereas
MOPC 315 cells synthesize an apparently normal protein
which is rapidly degraded (Goldberg et al., 1983). To
distinguish between these two alternatives for clone 2 cells, we
biosynthetically radiolabelled the cells with [35S]methionine
for 30 minutes, and immunoprecipitated labelled ciM6PR from
the clarified cell lysate. As shown in Fig. 2, in contrast to the
parental cells or clones 1, 3, and 4, radiolabelled ciM6PR was
undetectable in clone 2 immunoprecipitates, consistent with a
failure to synthesize this protein. No increase in signal was
observed in clone 2 cells pre-treated with either the proteosome
inhibitor lactacystin, or the lysosomal hydrolase inhibitor E64d
(data not shown). No correlation between the expression of the
protein encoded by the cDNA with which the various clones
had been transfected (a kinase-dead rat Vps34p,) and the
expression of ciM6PR could be determined (data not shown).
Thus it appeared that loss of ciM6PR expression from clone 2
was unrelated to the expression of the cDNA with which it had
been transfected, and was a consequence of the transfection
and/or selection procedure per se.
Clone 2 cells contain functional lysosomal
hydrolases
In addition to the ciM6PR, mammalian cells also possess a
second M6PR, the 46 kDa cation-dependent receptor (cdM6PR;
Dahms et al., 1989). Although neither receptor can completely
compensate for the loss of the other, intracellular concentrations
of lysosomal hydrolases are typically between 40% and 80% of
control levels in mouse fibroblasts lacking either the ciM6PR
or cdM6PR (Ludwig et al., 1994; Pohlmann et al., 1995).
Consistent with the hypothesis that lysosomal hydrolases would
still be targeted efficiently via the cdM6PR in clone 2 cells,
cathepsin D could readily be detected by indirect
immunofluorescence (Fig. 3A and B). Typically cathepsin D
staining was slightly less intense in clone 2 cells than in the other
lines tested (compare A and B), which correlates with the modest
increase in secretion of newly synthesized procathepsin D from
this cell line which we observed (data not shown). However, no
difference in the abilities of the various clones to degrade
endocytosed proteins was seen (data not shown).
The appearance of the TGN marker protein TGN38 (Luzio
et al., 1990), was essentially identical in all of the clones
Fig. 1. Western blotting of Rat1 cell lines. Equal numbers of parental
Rat1 fibroblasts (P), and clones 1-4, were harvested and processed
for immunoblotting as described in Materials and Methods. Prior to
antibody treatment, blots were stained with Ponceau S (Sigma), and
divided into regions containing the 300 kDa ciM6PR and the 100
kDa γ-adaptin subunit of AP-1. Each region was then processed with
the appropriate primary and secondary antibody solutions.
Fig. 2. Biosynthetic radiolabelling of ciM6PR. Parental Rat1
fibroblasts (P), and clones 1-4, were radiolabelled for 30 minutes
with [35S]methionine as described in Materials and Methods.
Labelled ciM6PR was recovered from clarified cell lysates by
immunoprecipitation, and detected by SDS-PAGE and
phosphorimaging.
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examined (Fig. 3C and D), as was the
distribution of the early endosomal marker
protein EEA1 (Mu et al., 1995; Fig. 3E
and F). In contrast, an abnormally intense
staining pattern for the lysosomal membrane
protein lgp120 was seen in the mutant cell
line (compare I and J), although analysis of
the steady state levels of lgp120 in the
various cell lines did not reveal any
significant differences (data not shown).
Consistent with the other results described
above, ciM6PR staining was undetectable in
clone 2 cells (G and H). In all microscopic
studies, clone 1 was a representative
example of ciM6PR expressing Rat1 cells.
In addition to degrading exogenous
proteins, DCLs are also required for turnover
of intracellular organelles and proteins by
macroautophagy. Recent studies have
implicated mammalian Vps34p in the
control of this process (Petiot et al., 2000).
Thus although we did not believe that the
defect in ciM6PR expression by clone 2 was
directly due to expression of the mutant
Vps34p encoded by the cDNA with which it
was transfected, we thought it important
to examine autophagy in this cell line.
As shown in Fig. 4A, degradation of
radiolabelled proteins in response to amino
acid deprivation occurred to an essentially
identical extent in clone 1 and clone 2 cells
during the 4 hour chase. Importantly, and
consistent with the reported involvement of
Vps34p (Petiot et al., 2000), starvation-
induced autophagy was significantly
inhibited by treatment with wortmannin
and 3-methyladenine, in addition to the
lysosmotrophic drug chloroquine (Fig. 4B).
As predicted, no significant difference in the
inhibitor sensitivities of induced protein
turnover in clones 1 and 2 was observed (Fig.
4B, compare open and solid bars). 
Clone 2 cells accumulate LBPA and
unesterified cholesterol
Recent studies have identified the unusual
acidic phospholipid LBPA (also known
as bis(monoacylglycero)phosphate) as a
marker of internal membranes in late
B. J. Reaves and others
Fig. 3. Immunofluorescence microscopy of
transfected Rat1 fibroblasts. Clone 1 (a
representative of Rat1 cell lines expressing
ciM6PR) and clone 2 cells were fixed with
methanol and processed for indirect
immunofluorescence as described in Materials
and Methods. The panels show the localizations
of rat cathepsin D, TGN38 (Luzio et al., 1990),
EEA1 (Mu et al., 1995), ciM6PR (using an
antibody to the cytosolic tail; Reaves et al.,
1996), and lgp120 (Grimaldi et al., 1987; Reaves
et al., 1996). 
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endosomal/prelysosomal compartments (Kobayashi et al.,
1998b), and shown that this lipid accumulates in some LSDs
(Kobayashi et al., 1999). Given the unusual staining pattern of
lgp120 in clone 2 cells (Fig. 3J), we thought it important to
examine LBPA distribution in these cells. As shown in Fig. 5A,
in clone 1 cells LBPA staining was confined to a restricted
number of widely distributed punctate structures together with
a diffuse peri-nuclear localization. In contrast, LBPA staining
in clone 2 cells was considerably more intense, and focussed
in the peri-nuclear region (C). A link between LBPA
accumulation and the trafficking of un-esterified cholesterol
has recently been demonstrated (Kobayashi et al., 1999).
Consistent with this observation, staining with the fluorescent
antibiotic filipin was considerably brighter in clone 2 cells as
compared to the other clones (compare B and D), and in
contrast to the control cells, showed extensive overlap with the
LBPA staining.
Recent studies have also shown that LBPA and cholesterol
accumulation can be induced by treatment of cells with the
hydrophobic amine U18666A (Kobayashi et al., 1999). As
predicted, treatment of clone 1 cells with U18666A caused an
increase in anti-LBPA and filipin staining, and a redistribution
of LBPA into the cholesterol-rich structures (Fig. 5E and F).
Under these conditions the drug-treated clone 1 cells could not
be distinguished from untreated clone 2 cells (compare C and
D with E and F). In contrast, no additional effect on LBPA and
cholesterol staining in clone 2 cells was observed following
treatment with U18666A (G and H).
LBPA accumulates in MLBs in clone 2 cells
To further characterise the structures in which LBPA
accumulated we conducted electron microscopic and
morphometric analyses of the various late endocytic structures
in Rat1 fibroblasts. Consistent with our previous analyses of
NRK fibroblasts (Bright et al., 1997), in control cells greater
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Fig. 4. Analysis of starvation-induced
autophagy in clones 1 and 2. Clone 1 or 2
cells (>80% confluent) were labelled for
16 hours with [35S]methionine as
described in Materials and Methods.
(A) Labelled cells were starved of
amino-acids without additions and
autophagy assessed. Results represent the
mean ± s.d. of 11 separate
determinations. (B) Labelled clone 1
cells (closed bars) or clone 2 cells (open
bars) were starved of amino-acids in the
presence of 100 nM wortmannin (WM),
10 mM 3-methyladenine (3-MA), or 200
µM chloroquine (CQ), and autophagy
assessed. Results are expressed relative
to cells starved in the absence of any
inhibitors, and represent the mean ± s.d
of 3 separate determinations.
Fig. 5. LBPA and cholesterol localization in clones 1 and 2.
(A,B,E,F) Clone 1 (a representative of Rat1 cell lines expressing
ciM6PR) and (C,D,G,H) clone 2 cells were incubated in the presence
or absence of 3 µg/ml U18666A, fixed with 2% paraformaldehyde in
PBS, and processed for indirect immunofluorescence as described in
Materials and Methods. LBPA was visualised using monoclonal 6C4
(Kobayashi et al., 1998b), and unesterified cholesterol with filipin.
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than 80% of the organelles labelled by BSA-gold following a
4 hour pulse and 20 hour chase were DCLs (Fig. 6A and C).
In contrast, the most abundant BSA-gold labelled structures in
clone 2 cells were identified as MLBs (B and C). Quantitative
analysis revealed that the average number of labelled
organelles per cell profile was reduced by almost 50% in the
mutant cell line (2.03 vs 1.16), but that the number of MLBs
was increased almost 3-fold (D). Moreover, the mean diameter
of these organelles was significantly greater in clone 2 cells as
compared to the other cell lines (510±25 nm vs 370±30 nm;
E). Together this resulted in the total cellular volume occupied
by late endocytic organelles in clone 2 cells becoming at least
1.5 times greater than that of the other cell lines. Quantitative
immuno-staining confirmed that the internal membranes of the
MLBs contained the bulk of the cell associated LBPA, and
showed that the aberrant structures present in clone 2 cells
contained approximately 2.5-fold more LBPA than the
equivalent structures in the control cells (Fig. 7).
LBPA accumulation can be reversed by re-
expressing ciM6PRs
The data presented above suggests that the loss of ciM6PR
expression is associated with a defect in DCL biogenesis,
which leads to LBPA and cholesterol accumulation. To confirm
B. J. Reaves and others
Fig. 6. Electron
microscopy and
morphometry. Clone 1 and
clone 2 Rat1 fibroblasts
were allowed to endocytose
BSA-5 nm gold (A,B,
arrows) and processed for
electron microscopy as
described in Materials and
Methods.
(A,B) Representative thin-
sections showing electron
dense lysosomes and late
endocytic structures in
clone 1 (A) and clone 2 (B)
cells. Bar, 200 nm. 
(C-E) Quantitation from
sections of clone 1 cells
(open bars) or clone 2 cells
(filled bars) of the
proportion of late
endosomes (LE),
multilamellar bodies
(MLB), and dense core
lysosomes (DCL) labelled
with BSA-gold (C), of the
number of BSA-gold
labelled structures per cell
profile (D), and of the
diameter of the labelled
structures (E). 
Fig. 7. Immunogold labelling of late endocytic structures. Clone 1
and clone 2 Rat1 fibroblasts were allowed to endocytose BSA-5 nm
gold (A,B, arrows) and processed for immunoelectron microscopy as
described in Materials and Methods. (A,B) Representative frozen
thin sections immunolabelled with the late endosome/lysosome
phospholipid marker LBPA (10 nm gold, arrowheads) from clone 1
(A) and clone 2 (B) cells. Bar, 200 nm. (C) Quantitation of the
density of LBPA labelling of BSA-gold loaded late endocytic
structures in clone 1 (open bars) or clone 2 (filled bars) cells. 
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that this is a direct effect we investigated whether it could be
reversed by expressing the bovine ciM6PR. The data shown in
Fig. 8 shows clearly that this is the case. In a mixed population
of clone 2 cells transfected with cDNA encoding the bovine
receptor, only those cells showing normal ciM6PR
distributions showed a normal LBPA staining pattern (compare
the LBPA staining in the upper 3 cells which are ciM6PR
positive with that in the lower 3 cells which are negative). This
eliminates the possibility that the ciM6PR loss was a
consequence of the LBPA accumulation, or that they were un-
connected events.
DISCUSSION
The results described above demonstrate that loss of ciM6PR
expression in Rat1 fibroblasts causes the accumulation of
abnormal MLBs. Loss of the receptor occurred spontaneously,
and at present we are uncertain of the precise mechanism
responsible. Since clone 2 cells were selected following
transfection with a dominant negative form of rat Vps34p, our
initial assumption was that loss of ciM6PR was directly
attributable to expression of the mutant protein. However,
closer examination provided abundant evidence that this was
not the case. Loss of ciM6PR synthesis was not observed in
numerous other clones from the same, or a subsequent,
transfection, many of which expressed equal or greater basal
levels of mutant Vps34p. Similarly, an equivalent phenotype to
that expressed by clone 2 could not be obtained in any other
clone by heavy metal ion mediated induction of the
metallothionein promotor controlling expression of the mutant
cDNA. Recent reports which utilised the alternative approach
of anti-sense oligonucleotide treatment to disrupt Vps34p
function indicated that loss of this enzymatic activity resulted
in an inhibition of starvation-induced autophagy (Petiot et al.,
2000), and perturbation of EEA1 localization (Siddhanta et al.,
1998). Neither of these effects was manifest in uninduced clone
2 cells, which strongly suggests that the low levels of mutant
Vps34p expressed in the absence of heavy metal ion mediated
induction are insufficient to negate the endogenous wild-type
protein expressed by the cells. 
In addition to its role in lysosomal enzyme delivery, the
300kDa cation-independent M6PR (ciM6PR) also functions
as an endocytic receptor for other ligands including insulin-
like growth factor II, retanoic acid, and urokinase-type
plasminogen activator receptor (reviewed by Braulke, 1999).
The gene encoding the ciM6PR is imprinted, and in rodents,
only the maternal allele is expressed in peripheral tissues (Mills
et al., 1998). Thus loss of expression in clone 2 cells may
simply have arisen through disruption of the single functional
copy of the gene through direct integration of the transfected
plasmid. Alternatively, since expression is controlled through
differential methylation of elements within the maternal and
paternal alleles, the transfection and/or selection procedure
may have perturbed this process, leading to inappropriate
silencing of the active gene in clone 2 cells. This explanation
appears more consistent with the observation that ciM6PR
expression is lost or greatly reduced in many human and mouse
tissue culture cell lines (for example Goldberg et al., 1983;
Wenk et al., 1991) and has been identified as a suppressor gene
in several human tumours (Devi et al., 1999). Nevertheless,
whatever the mechanism by which expression was lost, we
considered the resultant morphological changes in the late
endosomal organelles to be of sufficient interest to warrant
further investigation. In particular we were intrigued by the
possibility that the unusual structures we observed might be
related to some of the inclusion bodies detected in LSDs.
LSD inclusion bodies contain material that would normally
be digested or exported from lysosomes (Gieselmann, 1995).
For example, the sphingolipidoses such as Gaucher’s, Faber’s,
and Fabry’s diseases all result in accumulation of ceramide
derivatives, whilst Pompe’s disease patients accumulate
glycogen. Inclusion bodies accumulate endocytosed probes,
indicating that they are derived from the late endocytic
pathway, and in the most severe cases may represent up to 50%
of the total cell volume (Karageorgos et al., 1997). However,
their precise relationship to the remainder of the endocytic
compartments remains unclear. Recently, analysis of cells
Fig. 8. Expression of
bovine ciM6PR in
clone 2 cells. Clone 2
cells were transfected
with pSREP93-bovine
ciM6PR as described
in Materials and
Methods. After 10 days
selection with
puromycin the cells
were fixed in 2%
paraformaldehyde and
stained for ciM6PR
using the polyclonal
antiserum (which
recognises an epitope
conserved between the
rat and bovine
enzymes; top panel)
and LBPA (centre
panel). The merged
image is shown in the
lower panel.
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derived from several distinct sphingolipidoses revealed that in
addition to the accumulation of products whose metabolism is
impaired by the specific gene defect, there is also a common
disorder in lipid handling characterised by the accumulation
of un-esterified cholesterol and LBPA (Chen et al., 1999;
Ridgway, 2000). 
A similar defect in cholesterol and LBPA metabolism to that
observed in sphingolipidoses was seen in clone 2 cells
suggesting that a common mechanism might be involved. One
trivial possibility is that the ciM6PR is exclusively required for
the delivery of a key hydrolase to Rat1 endosomes, and that
loss of the receptor caused aberrant secretion of this enzyme,
and a consequent failure to degrade a key substrate. At present
we cannot exclude this possibility, but consider it unlikely to
be the correct explanation. Although the cdM6PR and ciM6PR
show different affinities for individual lysosomal hydrolases,
mouse fibroblasts lacking only one of the two receptors
typically contain at least 50% of the wild-type levels of each
enzyme (Pohlmann et al., 1995). The dominant feature in
determining the relative affinities of the two receptors appears
to be related to the number of phosphorylated oligosaccharides
possessed by an individual enzyme, and the number of
phosphate esters added to specific sugar chains, and to date no
hydrolase whose trafficking is entirely dependent on the
ciM6PR has been identified. Moreover, at least one key
component of sphingolipid metabolism, prosaposin, can be
retrieved from the extracellular medium by a non-M6P
dependent route (Hiesberger et al., 1998). 
An alternative explanation for the defect in clone 2 cells,
which we favour, is that it is directly due to a perturbation of
the balance of membrane flux within the endocytic pathway,
resulting from the reduction of membrane recycling from late
endosomes to the TGN. At present there is considerable debate
concerning the organization and function of the late endosomal
pathway. Traditional ultrastructural analysis following
labelling with endocytosed probes typically reveals an
heterogeneous population of vesicular structures clustered in
the peri-nuclear region of the cell. Based upon the kinetics of
labelling by internalised probes, the degree of electron density,
the appearance of internal membranes, and the presence or
absence of particular marker proteins, various organelles
such as multi-vesicular bodies (MVBs), prelysosomal
compartments (PLCs), MLBs, ELHs, and DCLs have been
defined. However, in many cases there is significant variation
between the structures seen in different cell types, and it
remains difficult to extrapolate data between distinct tissues.
Part of the apparent inconsistency can be reconciled by the
realisation that the entire endocytic pathway is much more
dynamic than has previously been recognised (Sönnichsen et
al., 2000). Thus the variations between tissues at steady state
may simply reflect differences in the net flux of membrane and
cargo into and out of individual endocytic compartments, and
the consequent accumulation of distinct intermediates in each
cell type. 
Studies on clathrin adaptor complex AP-1 binding to the
TGN have indicated that it is directly influenced by the levels
of M6PRs (Le Borgne and Hoflack, 1997), suggesting that the
receptors are directly involved in nucleating transport vesicle
formation. Although the precise mechanism by which
ciM6PRs are retrieved from late endosomes is currently
uncertain, it is likely that a coat complex is involved, and that
recruitment and subsequent vesicle formation is at least
partially dependent upon the presence of the cargo (Rohn et
al., 2000). Thus loss of the ciM6PR might reduce the rate of
recycling of material from the late endocytic pathway to the
TGN. In this regard it should be noted that studies of the
Niemann-Pick type C protein NPC1, which is implicated in the
retrieval of cholesterol from late endocytic compartments, have
revealed a close association with ciM6PRs. NPC1 also appears
to cycle between endosomes and the TGN (Mukherjee
and Maxfield, 1999), and cells expressing mutant NPC1
accumulate both cholesterol and ciM6PR in LBPA rich
membranes (Kobayashi et al., 1999). This observation is
consistent with the hypothesis that the trafficking of NPC1 and
ciM6PR from late endosomal compartments are related events,
even though they may not share the same transport vesicles,
and that the loss of ciM6PRs might directly inhibit NPC1
transport, which would lead to the lipid accumulation which
we observed. 
Our results clearly indicate that trafficking of endocytosed
material to DCLs is inhibited in clone 2 cells. However, at
present we are uncertain as to the precise nature of the MLBs
that accumulate in clone 2 cells, and hence the stage at which
the block is occurring. Two distinct possibilities exist, the first
of which is that it is fusion between endosomes and lysosomes
which is inhibited. Consistent with this hypothesis is the
observation of structures showing a distinct resemblance to
those seen in clone 2 cells in human Hep2 cells during a study
in which late endosome-lysosome fusion was prevented by
ablation of the DCLs with HRP (Futter et al., 1996). Under the
inhibitory conditions used by Futter and colleagues the pre-
lysosomal organelles observed in Hep2 cells became swollen
and accumulated internal membranes. This suggests that if
fusion is inefficient, or occurs at a slower rate than the
accumulation of LBPA, MLBs can arise from the maturation
of MVBs. Such a hypothesis is consistent with the morphology
of the PLCs seen in NRK cells (Griffiths et al., 1988).
Moreover, our recent studies have highlighted the importance
of the internal milieu of endosomes and lysosomes in the
fusion event (Pryor et al., 2000), which might explain how
accumulation of material within a pre-lysosomal compartment
could prevent its subsequent fusion.
However, it should be noted that the MLBs in clone 2 were
electron dense, consistent with their containing active
lysosomal enzymes. This appears to be in contrast with the
arrested structures detected in Hep2 cells, which were unable
to degrade EGF-EGF receptor complexes (Futter et al., 1996).
Although newly synthesized hydrolases delivered from the
early endocytic pathway or TGN may become active in late
endosomes, our previous studies have suggested that the
acquisition of electron density is primarily a consequence of
ELH formation (Bright et al., 1997). This suggests an
alternative hypothesis in which the MLBs which accumulate
in clone 2 cells are abnormal ELHs. In this regard it is
interesting to note that DCLs morphologically similar to the
structures observed in rat liver, appear to be present at
particularly low levels, or absent, in many tissue culture cell
lines, and that in such cells structures resembling MLBs are
regarded as lysosomes (for example Kleijmeer et al., 1997).
The acquisition of a dense-core is probably related to the
balance between the generation of degraded material within
‘lysosomes,’ and the export of this material into the cytoplasm.
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Our current model suggests that re-condensed ELHs can
undergo multiple rounds of fusion (Luzio et al., 2000), which
might lead to a gradual accumulation of electron dense
material. Thus accumulation of material within ELHs in clone
2 cells might lower the efficiency of re-condensation, and
consequently reduce the rate of maturation into DCLs.
However, whatever the precise mechanism involved in the
accumulation of the aberrant MLBs in clone 2 cells, our results
clearly indicate a link in membrane trafficking events and
storage disorders, and highlight the importance of trafficking
within the late endocytic pathway in the development of the
pathologies of LSDs.
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